Metagenomi Announces Publication of Data in Nature Communications Describing Novel, Ultra-Small Nucleases for Gene Editing
EMERYVILLE, Calif.--(BUSINESS WIRE)--Metagenomi, a genetic medicines company with a versatile portfolio of wholly owned, next-generation gene editing tools, today announced the publication of data in Nature Communications describing novel, compact RNA-guided nucleases used to develop the smallest adenine base editor to date. These nucleases are highly active and have broad...
